相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Knockdown of RIPK2 Inhibits Proliferation and Migration, and Induces Apoptosis via the NF-κB Signaling Pathway in Gastric Cancer
Qian Yang et al.
FRONTIERS IN GENETICS (2021)
ERRα activates SHMT2 transcription to enhance the resistance of breast cancer to lapatinib via modulating the mitochondrial metabolic adaption
Xin Li et al.
BIOSCIENCE REPORTS (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling
Cheng Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
RBP EIF2S2 Promotes Tumorigenesis and Progression by Regulating MYC-Mediated Inhibition via FHIT-Related Enhancers
Jiwei Zhang et al.
MOLECULAR THERAPY (2020)
Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNγ axis
Yung-Chieh Chan et al.
ONCOGENE (2020)
Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation
Hirofumi Yoshino et al.
MOLECULAR ONCOLOGY (2020)
Identifying the novel key genes in renal cell carcinoma by bioinformatics analysis and cell experiments
Yeda Chen et al.
CANCER CELL INTERNATIONAL (2020)
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma
Sifan Yu et al.
CELL DEATH & DISEASE (2019)
SHMT2 Promotes Liver Regeneration Through Glycine-activated Akt/mTOR Pathway
Menghao Wang et al.
TRANSPLANTATION (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Study of SHMT2 Inhibitors and Their Binding Mechanism by Computational Alanine Scanning
Liping He et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells
Lijuan Ji et al.
MEDICAL SCIENCE MONITOR (2019)
Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism
Ilaria Marrocco et al.
CELLS (2019)
Serine Catabolism by SHMT2 Is Required for Proper Mitochondrial Translation Initiation and Maintenance of Formylmethionyl-tRNAs
Denise R. Minton et al.
MOLECULAR CELL (2018)
Mice deficient in the &ITShmt2&IT gene have mitochondria&FACT; respiration defects and are embryonic lethal
Haruna Tani et al.
SCIENTIFIC REPORTS (2018)
SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
Shanglei Ning et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2018)
SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation
Xin Yang et al.
CANCER RESEARCH (2018)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors
Stephan Bernhardt et al.
BREAST CANCER RESEARCH (2017)
Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma
Chern Chiuh Woo et al.
ONCOTARGET (2016)
SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance
Dohoon Kim et al.
NATURE (2015)
Mitochondria as biosynthetic factories for cancer proliferation
Christopher S. Ahn et al.
CANCER & METABOLISM (2015)
Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes
Genee Y. Lee et al.
CANCER RESEARCH (2014)
Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time
Guillaume Ploussard et al.
EUROPEAN UROLOGY (2014)
A BRISC-SHMT Complex Deubiquitinates IFNAR1 and Regulates Interferon Responses
Hui Zheng et al.
CELL REPORTS (2013)
Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
Ju-Seog Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
Wun-Jae Kim et al.
MOLECULAR CANCER (2010)
PrognoScan: a new database for meta-analysis of the prognostic value of genes
Hideaki Mizuno et al.
BMC MEDICAL GENOMICS (2009)
DNA Microarray Expression Profiling of Bladder Cancer Allows Identification of Noninvasive Diagnostic Markers
Lourdes Mengual et al.
JOURNAL OF UROLOGY (2009)
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
M Sanchez-Carbayo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Bladder cancer outcome and subtype classification by gene expression
E Blaveri et al.
CLINICAL CANCER RESEARCH (2005)
Gene expression in the urinary bladder:: A common carcinoma in situ gene expression signature exists disregarding histopathological classification
L Dyrskjot et al.
CANCER RESEARCH (2004)
分享论文
